DWA
AMGN icon

Douglass Winthrop Advisors’s Amgen AMGN Stock Holding History

Douglass Winthrop Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.15M Sell
8,949
-415
-4% -$148K 0.06% 96
2025
Q4 		$3.06M Sell
9,364
-1,690
-15% -$536K 0.05% 95
2025
Q3 		$3.12M Sell
11,054
-95
-0.9% -$27.6K 0.05% 94
2025
Q2 		$3.11M Sell
11,149
-2,915
-21% -$826K 0.06% 93
2025
Q1 		$4.38M Sell
14,064
-76
-0.5% -$22.4K 0.08% 78
2024
Q4 		$3.69M Sell
14,140
-100
-0.7% -$29.7K 0.07% 85
2024
Q3 		$4.59M Sell
14,240
-10
-0.1% -$3.27K 0.09% 80
2024
Q2 		$4.45M Sell
14,250
-100
-0.7% -$29.4K 0.09% 75
2024
Q1 		$4.08M Buy
14,350
+195
+1% +$57.1K 0.08% 79
2023
Q4 		$4.08M Hold
14,155
– – 0.09% 74
2023
Q3 		$3.8M Sell
14,155
-575
-4% -$143K 0.09% 74
2023
Q2 		$3.27M Buy
14,730
+68
+0.5% +$15.8K 0.08% 82
2023
Q1 		$3.54M Sell
14,662
-159
-1% -$39K 0.09% 77
2022
Q4 		$3.89M Sell
14,821
-200
-1% -$53.6K 0.11% 72
2022
Q3 		$3.39M Sell
15,021
-582
-4% -$141K 0.1% 72
2022
Q2 		$3.8M Buy
15,603
+114
+0.7% +$27.9K 0.11% 68
2022
Q1 		$3.75M Sell
15,489
-5,575
-26% -$1.28M 0.09% 77
2021
Q4 		$4.74M Sell
21,064
-7,120
-25% -$1.5M 0.11% 73
2021
Q3 		$5.99M Sell
28,184
-178
-0.6% -$41K 0.15% 55
2021
Q2 		$6.91M Sell
28,362
-272
-0.9% -$66.9K 0.17% 48
2021
Q1 		$7.12M Sell
28,634
-2,350
-8% -$561K 0.19% 44
2020
Q4 		$7.12M Buy
30,984
+59
+0.2% +$13.6K 0.2% 43
2020
Q3 		$7.86M Sell
30,925
-78,400
-72% -$19.4M 0.26% 42
2020
Q2 		$25.8M Sell
109,325
-9,855
-8% -$2.25M 0.96% 33
2020
Q1 		$24.2M Sell
119,180
-203,521
-63% -$44.5M 1.08% 32
2019
Q4 		$77.8M Buy
322,701
+2,745
+0.9% +$605K 2.75% 10
2019
Q3 		$61.9M Buy
319,956
+17,651
+6% +$3.39M 2.37% 15
2019
Q2 		$55.7M Buy
302,305
+13,685
+5% +$2.45M 2.24% 18
2019
Q1 		$54.8M Buy
288,620
+4,530
+2% +$865K 2.39% 14
2018
Q4 		$55.3M Buy
284,090
+16,685
+6% +$3.26M 2.75% 9
2018
Q3 		$55.4M Buy
267,405
+3,688
+1% +$727K 2.45% 11
2018
Q2 		$48.7M Sell
263,717
-1,974
-0.7% -$349K 2.19% 14
2018
Q1 		$45.3M Buy
265,691
+35,053
+15% +$6.43M 2.21% 12
2017
Q4 		$40.1M Buy
230,638
+3,688
+2% +$653K 2.18% 16
2017
Q3 		$42.3M Sell
226,950
-1,879
-0.8% -$333K 2.46% 11
2017
Q2 		$39.4M Buy
228,829
+5,312
+2% +$864K 2.39% 11
2017
Q1 		$36.7M Buy
223,517
+8,068
+4% +$1.34M 2.29% 13
2016
Q4 		$31.5M Buy
215,449
+21,638
+11% +$3.26M 2.13% 16
2016
Q3 		$32.3M Buy
193,811
+5,978
+3% +$1.01M 2.23% 15
2016
Q2 		$28.6M Buy
187,833
+12,076
+7% +$1.88M 2.02% 21
2016
Q1 		$26.4M Buy
175,757
+153,253
+681% +$22.8M 1.9% 19
2015
Q4 		$3.65M Buy
22,504
+1,350
+6% +$212K 0.27% 66
2015
Q3 		$2.93M Buy
21,154
+1,300
+7% +$205K 0.23% 67
2015
Q2 		$3.17M Hold
19,854
– – 0.25% 66
2015
Q1 		$3.17M Buy
19,854
+4,790
+32% +$754K 0.25% 66
2014
Q4 		$2.4M Sell
15,064
-5
-0% -$779 0.21% 67
2014
Q3 		$2.12M Buy
15,069
+3,635
+32% +$475K 0.2% 65
2014
Q2 		$1.35M Hold
11,434
– – 0.12% 80
2014
Q1 		$1.41M Buy
11,434
+3,100
+37% +$376K 0.14% 75
2013
Q4 		$951K Sell
8,334
-22
-0.3% -$2.5K 0.1% 87
2013
Q3 		$935K Buy
8,356
+66
+0.8% +$7.16K 0.11% 82
2013
Q2 		$818K Buy
+8,290
New +$860K 0.1% 86

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Douglass Winthrop Advisors's AMGN Position: Q1 2026 in Review

Douglass Winthrop Advisors reduced its Amgen (AMGN) stake by 4.4% in Q1 2026, selling an estimated $148K and leaving 8,949 shares worth $3.15M. The position accounts for 0.06% of the portfolio, ranked #96.

Douglass Winthrop Advisors first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $77.8M in Q4 2019. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Douglass Winthrop Advisors held 8,949 shares of Amgen worth $3.15M as of Q1 2026.
  • Douglass Winthrop Advisors sold 415 Amgen shares in Q1 2026, an estimated $148K.
  • Amgen made up 0.06% of Douglass Winthrop Advisors's portfolio in Q1 2026, its #96 holding.
  • Douglass Winthrop Advisors first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Douglass Winthrop Advisors's Amgen position peaked at $77.8M in Q4 2019.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Douglass Winthrop Advisors's 13F filing for Q1 2026, filed 14 May 2026.